Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The screenshots depict the same history page with only minor UI/organizational changes and a new version entry added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T18:32:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding lapse notice and the Revision: v3.4.1 note were removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:23:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status. Updated the revision tag from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:46:19.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page now includes a glossary display option and color-coded legends for additions and deletions, and revision notes have been updated from v3.3.4 to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-01-28T06:11:02.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:01:42.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' item and the older 'Revision: v3.3.2' entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:29:45.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.